Barraquer Dubai adds Dr Ania Buigues for 6-day oculoplastic visit from 27 August

Barraquer Eye Hospital UAE will host Dr Ania Buigues Llull, a visiting consultant ophthalmologist from Spain, in Dubai from 27 August to 1 September 2026, according to a press release carried by regional media.

The highest-stakes readers are clinic operators, insurers and patients with time-sensitive oculoplastic demand. For Dubai clinics, the visit is a signal that subspecialty ophthalmology can be packaged around short consultant windows. For payers, it raises the usual questions on pre-authorisation, cosmetic exclusions and medical necessity. For patients in Dubai, Abu Dhabi and the northern emirates, the practical issue is whether a consultation during a six-day visit can lead to follow-up care after the consultant leaves the UAE.

What Barraquer announced

The announcement describes Dr Buigues as a Visiting Consultant Ophthalmologist and oculoplastic and aesthetic eye surgery specialist with more than 15 years of ophthalmology experience. Barraquer says her focus includes eyelid surgery, upper and lower blepharoplasty, brow lift, periorbital rejuvenation, Botox and fillers.

“Dr. Ania brings extensive experience in oculoplastic and aesthetic eye surgery.” — Barraquer Eye Hospital UAE medical team

Barraquer’s own medical-team page lists Dr Buigues as a visiting consultant ophthalmologist, with languages listed as English, German and Spanish. The same page says she has been European Board Certified since 2015 and is a Fellow of the European Board of Ophthalmology. The Dubai Health Authority (DHA) Sheryan directory lists Ania Isabel Buigues Llull as a consultant ophthalmologist with an active licence at Barraquer Eye Hospital FZ-LLC, licence 02402006-001, valid from 6 October 2021 to 5 October 2026.

Why clinics and insurers should care

For Dubai competitors, the relevant move is capacity design. A six-day specialist visit creates scarcity without adding a permanent full-time post. Clinics using visiting consultants need appointment triage, operating-room allocation, informed-consent workflows and documented handover for post-procedure review. In Dubai, that sits under DHA licensing and professional registration. In Abu Dhabi and Al Ain, operators should check Department of Health Abu Dhabi requirements before any cross-emirate clinical work. In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the relevant regulator is the Ministry of Health and Prevention (MOHAP).

Insurers should separate functional eyelid disease from elective aesthetic care before appointments are booked. Barraquer’s insurer page lists partnerships including Daman NW1 and NW2 and Sukoon Premium and Edge, but it also tells patients to check their own policy cover. That matters because blepharoplasty, Botox and fillers may fall into different benefit categories depending on diagnosis, visual-field findings, medical notes and pre-authorisation rules.

• Patients should confirm whether the consultation, diagnostics and procedure are covered before attending.
• Clinics should confirm the named doctor’s licence status in DHA Sheryan on the booking date.
• Insurers should request diagnosis codes, clinical photographs where required, and any visual-field evidence before approval.
• Referrers in Abu Dhabi and the northern emirates should confirm where follow-up will occur after 1 September 2026.

What patients should check before booking

Barraquer’s appointment guidance says a visit usually lasts between one and two hours, and that complementary tests are outside the appointment price. That is the number patients can act on. They should ask for the consultation fee, the likely diagnostic tests, the self-pay price for each test, the surgeon’s availability for review, and the claims route if using Daman, Sukoon or another listed payer.

For operators, the lesson is narrow. Specialist visiting sessions work when front-desk teams can answer five questions in writing: doctor licence, appointment duration, test pricing, payer eligibility and follow-up ownership. A vague answer creates complaints, delayed approvals and avoidable cancellations.

Patients comparing options should verify licensed ophthalmology providers through regulator directories first: DHA for Dubai, DOH for Abu Dhabi and Al Ain, and MOHAP for the northern emirates. They can also use the UAE Open Healthcare Directory to compare licensed ophthalmology providers before booking.